Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07032662
PHASE2

Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Sponsor: Immunovant Sciences GmbH

View on ClinicalTrials.gov

Summary

This is a Phase 2b study to evaluate the efficacy and safety of Imeroprubart in adults with CIDP.

Official title: A Phase 2b, Multi-center, Randomized, Double-blind, Placebo-controlled Study of IMVT-1402 Treatment in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

162

Start Date

2025-03-18

Completion Date

2030-05

Last Updated

2026-09-30

Healthy Volunteers

No

Interventions

DRUG

Imeroprubart

Dose 1 subcutaneous (SC) once weekly (QW) for 24 weeks (Period 1) and 52 weeks (Period 2)

DRUG

Placebo

Matching placebo SC QW for 24 weeks (Period 1)

Locations (142)

Site Number - 1612

Tucson, Arizona, United States

Site Number - 1618

Carlsbad, California, United States

Site Number - 1637

Mission Hills, California, United States

Site Number - 1619

Orange, California, United States

Site Number - 1607

Rancho Mirage, California, United States

Site Number -1608

San Francisco, California, United States

Site Number - 1626

Parker, Colorado, United States

Site Number - 1621

New Haven, Connecticut, United States

Site Number - 1630

Washington D.C., District of Columbia, United States

Site Number - 1601

Washington D.C., District of Columbia, United States

Site Number - 1603

Maitland, Florida, United States

Site Number - 1606

Miami, Florida, United States

Site Number - 1617

Ormond Beach, Florida, United States

Site Number - 1620

Port Charlotte, Florida, United States

Site Number - 1633

Rockledge, Florida, United States

Site Number - 1632

Chicago, Illinois, United States

Site Number - 1602

Kansas City, Kansas, United States

Site Number - 1611

Nicholasville, Kentucky, United States

Site Number - 1623

Boston, Massachusetts, United States

Site Number - 1625

Worcester, Massachusetts, United States

Site Number - 1629

Detroit, Michigan, United States

Site Number - 1634

Las Vegas, Nevada, United States

Site Number - 1605

New York, New York, United States

Site Number - 1627

New York, New York, United States

Site Number - 1635

Chapel Hill, North Carolina, United States

Site Number - 1610

Charlotte, North Carolina, United States

Site Number - 1624

Canton, Ohio, United States

Site Number - 1631

Yukon, Oklahoma, United States

Site Number - 1614

Portland, Oregon, United States

Site Number - 1616

Philadelphia, Pennsylvania, United States

Site Number - 1622

Houston, Texas, United States

Site Number - 1628

San Antonio, Texas, United States

Site Number - 1613

Milwaukee, Wisconsin, United States

Site Number - 5005

Rosario, Santa Fe Province, Argentina

Site Number - 5002

Buenos Aires, Argentina

Site Number - 5006

Buenos Aires, Argentina

Site Number - 5001

Córdoba, Argentina

Site Number - 5003

Córdoba, Argentina

Site Number - 5000

Rosario, Argentina

Site Number - 5100

Macquarie Park, Australia

Site Number - 5103

Parkville, Australia

Site Number - 5102

Woolloongabba, Australia

Site Number - 5200

Vienna, Austria

Site Number - 5300

Leuven, Belgium

Site Number - 5400

Banja Luka, Bosnia and Herzegovina

Site Number - 5402

Bihać, Bosnia and Herzegovina

Site Number - 5401

Mostar, Bosnia and Herzegovina

Site Number - 5403

Sarajevo, Bosnia and Herzegovina

Site Number - 5507

Belo Horizonte, Brazil

Site Number - 5506

Brasília, Brazil

Site Number - 5503

Campinas, Brazil

Site Number - 5500

Curitiba, Brazil

Site Number - 5502

Joinville, Brazil

Site Number - 5501

Porto Alegre, Brazil

Site Number - 5504

Porto Alegre, Brazil

Site Number - 5505

Vila Clementino, Brazil

Site Number - 5601

Pleven, Bulgaria

Site Number - 5600

Sofia, Bulgaria

Site Number - 5602

Sofia, Bulgaria

Site Number - 5603

Sofia, Bulgaria

Site Number - 5604

Sofia, Bulgaria

Site Number - 5800

Bogotá, Colombia

Site Number - 3600

Copenhagen, Denmark

Site Number - 3601

Odense, Denmark

Site Number - 7251

Tallinn, Estonia

Site Number - 3800

Turku, Finland

Site Number - 6505

Berlin, Germany

Site Number - 6501

Bochum, Germany

Site Number - 6504

Essen, Germany

Site Number - 6500

Tübingen, Germany

Site Number - 6503

Ulm, Germany

Site Number - 6502

Würzburg, Germany

Site Number - 3901

Alexandroupoli, Greece

Site Number - 3902

Athens, Greece

Site Number - 3905

Chaïdári, Greece

Site Number - 3906

Heraklion, Greece

Site Number - 3903

Ioannina, Greece

Site Number - 3904

Larissa, Greece

Site Number - 3900

Pátrai, Greece

Site Number - 7551

Budapest, Hungary

Site Number - 7550

Kistarcsa, Hungary

Site Number - 7552

Pécs, Hungary

Site Number - 4100

Waterford, Ireland

Site Number - 6004

Bergamo, Italy

Site Number - 6007

Bologna, Italy

Site Number - 6000

Brescia, Italy

Site Number - 6009

Milan, Italy

Site Number - 6001

Milan, Italy

Site Number -6005

Milan, Italy

Site Number - 6011

Pavia, Italy

Site Number - 6010

Pisa, Italy

Site Number - 6002

Roma, Italy

Site Number - 6006

Roma, Italy

Site Number - 6003

Siena, Italy

Site Number - 2603

Colonia del Valle, Mexico

Site Number - 2600

Culiacán, Mexico

Site Number - 2602

Tlalpan, Mexico

Site Number - 2601

Veracruz, Mexico

Site Number - 2200

Utrecht, Netherlands

Site Number - 2300

Oslo, Norway

And 42 more locations on ClinicalTrials.gov